Andere talen InterCure Ltd. Nasdaq

Aandelen

INCR

IL0011063760

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 10-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,4 ^USD	-1,23%		-17,53%	+86,08%

01/05	InterCure Ltd. Geeft omzetrichtlijnen voor het volledige jaar 2024	CI
01/05	InterCure Ltd. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference	22/05
InterCure : Immediate Report	21/05
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million	01/05
InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	01/05
InterCure : FORM 20-F For the fiscal year ended December 31, 2023	01/05
InterCure : Announces FY2023 Result	01/05
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/05
InterCure : Preliminary results for the full year of 2023	01/04
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million	01/04
InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	01/04
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K	01/04
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint	22/03
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	22/03
InterCure Provides an Update Regarding Nir Oz Facility	13/02
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations	13/02
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain	31/01
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	31/01
InterCure : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 - Form 6-K	08/11
InterCure Wins Cannolam Arbitration Proceeding	31-10-23
InterCure Provides an Update Regarding the Security Situation in Israel	17-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen InterCure Ltd. Nasdaq

Aandelen

INCR

IL0011063760

Andere talen

Filters